Edge Capital Group, LLC Novartis Ag Transaction History

Edge Capital Group, LLC

$2.21 Billion
Q3 2024

A detailed history of Edge Capital Group, LLC transactions in Novartis Ag stock. As of the latest transaction made, Edge Capital Group, LLC holds 3,067 shares of NVS stock, worth $303,878. This represents 0.02% of its overall portfolio holdings.

Number of Shares

3,067

Previous 3,084 0.55%

Holding current value

$303,878

Previous $328,000 7.32%

% of portfolio

0.02%

Previous 0.02%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$106.13 - $120.89 $1,804 - $2,055	-17 Reduced 0.55%	3,067 $352,000
Q1 2024 May 14, 2024	BUY	$95.27 - $108.47 $19,720 - $22,453	207 Added 7.19%	3,084 $298,000
Q3 2023 Nov 13, 2023	SELL	$94.73 - $105.13 $17,051 - $18,923	-180 Reduced 5.89%	2,877 $293,000
Q1 2023 May 04, 2023	SELL	$80.03 - $92.81 $6,722 - $7,796	-84 Reduced 2.67%	3,057 $281,000
Q4 2022 Feb 07, 2023	BUY	$75.55 - $92.52 $6,346 - $7,771	84 Added 2.75%	3,141 $284,000
Q3 2022 Nov 09, 2022	SELL	$74.61 - $87.26 $5,744 - $6,719	-77 Reduced 2.46%	3,057 $232,000
Q2 2022 Aug 08, 2022	SELL	$80.52 - $93.75 $58,860 - $68,531	-731 Reduced 18.91%	3,134 $265,000
Q1 2022 May 03, 2022	BUY	$80.11 - $90.62 $58,320 - $65,971	728 Added 23.21%	3,865 $339,000
Q4 2021 Jan 19, 2022	SELL	$79.7 - $88.13 $79 - $88	-1 Reduced 0.03%	3,137 $274,000
Q3 2021 Oct 26, 2021	SELL	$81.78 - $95.14 $8,178 - $9,514	-100 Reduced 3.09%	3,138 $257,000
Q2 2021 Aug 09, 2021	SELL	$85.24 - $94.15 $83,535 - $92,267	-980 Reduced 23.23%	3,238 $295,000
Q1 2021 May 13, 2021	SELL	$83.5 - $98.47 $6.1 Million - $7.2 Million	-73,092 Reduced 94.54%	4,218 $361,000
Q4 2020 Feb 16, 2021	SELL	$78.07 - $94.43 $1.05 Million - $1.27 Million	-13,416 Reduced 14.79%	77,310 $7.3 Million
Q3 2020 Nov 09, 2020	BUY	$82.14 - $91.0 $2.6 Million - $2.88 Million	31,613 Added 53.48%	90,726 $7.89 Million
Q2 2020 Aug 11, 2020	SELL	$80.93 - $91.1 $1.9 Million - $2.14 Million	-23,512 Reduced 28.46%	59,113 $5.16 Million
Q1 2020 May 08, 2020	SELL	$70.67 - $99.01 $1.22 Million - $1.71 Million	-17,287 Reduced 17.3%	82,625 $6.81 Million
Q4 2019 Feb 11, 2020	SELL	$84.35 - $95.37 $1.23 Million - $1.39 Million	-14,539 Reduced 12.7%	99,912 $9.46 Million
Q3 2019 Nov 12, 2019	SELL	$85.54 - $94.26 $298,449 - $328,873	-3,489 Reduced 2.96%	114,451 $9.95 Million
Q2 2019 Jul 25, 2019	BUY	$75.4 - $92.8 $969,417 - $1.19 Million	12,857 Added 12.24%	117,940 $10.8 Million
Q1 2019 May 14, 2019	SELL	$75.32 - $86.15 $188,751 - $215,891	-2,506 Reduced 2.33%	105,083 $10.1 Million
Q4 2018 Feb 14, 2019	BUY	$73.66 - $82.02 $7.93 Million - $8.82 Million	107,589 New	107,589 $9.23 Million

Others Institutions Holding NVS

# of Institutions

1,437

Shares Held

131M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $213B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Edge Capital Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Edge Capital Group, LLC with notifications on news.

Account

Edge Capital Group, LLC Novartis Ag Transaction History